Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF ( DrugBank: G-CSF, Methotrexate, Tacrolimus, Busulfan, Fludarabine, Phosphate )

1 disease

ID	Disease name (Link within this page)	Number of trials
60	Aplastic anemia	1

60. Aplastic anemia

Clinical trials : 235 / Drugs : 381 - (DrugBank : 83) / Drug target genes : 44 - Drug target pathways : 160

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00516152 (ClinicalTrials.gov)	November 2002	13/8/2007	Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoiet ...	Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoiet ...	Chronic Myeloid Leukemia;Acute Myelogenous Leukemia;Myelodysplasia;Acute Lymphocytic Leukemia;Severe ...	Drug: Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF	University of California, San Francisco	NULL	Completed	15 Years	61 Years	Both	36	Phase 2	United States

First Previous1Next Last